Blocking molecular target could make more cancers treatable with PARP inhibitors
BOSTON--Researchers at Dana-Farber Cancer Institute have demonstrated a molecular strategy they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs.
Jun 29, 2011
0
0